Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

Share Price is delayed by 15 minutes
Get Live Data
88.00    0.00 (0.00%)
Bid:
86.00
Ask:
90.00
Spread: 4.00 (4.651%)
Market Cap: £98.77m
BBSN Live PriceLast checked at - London Stock Exchange

Intraday Brave Bison Share Chart

Director/PDMR Shareholding

29 Apr 2022 13:53

RNS Number : 9158J
Brave Bison Group PLC
29 April 2022
 

29 April 2022

 

Brave Bison Group plc

("Brave Bison" or the "Company")

 

 

Director/PDMR Shareholding

 

 

Brave Bison, the social and digital media company, announces that it has been notified that Philippa Norridge, Chief Financial Officer of the Company, has today purchased 111,111 ordinary shares in the Company at a price of 1.8 pence per ordinary share. Following this purchase, Philippa Norridge is interested in 851,111 ordinary shares in the Company, representing approximately 0.1 per cent. of the Company's issued ordinary share capital.

 

The notification below, made in accordance with the UK Market Abuse Regulation, provides further details.

 

For further information please contact:

 

Brave Bison Group plc

Oliver Green, Executive Chairman via Cenkos

Theo Green, Chief Growth Officer

Philippa Norridge, Chief Financial Officer

 

Cenkos Securities plc Tel: +44 (0)20 7397 8900

Nominated Adviser & Broker

Nicholas Wells

Ben Jeynes

 

 

 

 

 1

Details of the person discharging managerial responsibilities / person closely associated (PCA)

a)

Name

Philippa Norridge

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b) 

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Brave Bison Group plc

b)

LEI

213800BEII7EWIN8X308

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

ordinary shares of 0.1p each

 

 

Identification code (ISIN) for Brave Bison Group plc ordinary shares: GB00BF8HJ774

 

b)

Nature of the transaction

Acquisition of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1.8 pence

 

 

111,111

 

d)

Aggregated information

 

- Aggregated volume

- Price

 

N/A - single transaction

e)

Date of the transaction

29 April 2022

f)

Place of the transaction

AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLKLFLLZLEBBF
Date   Source Headline
1st Jun 20267:00 amRNSProposed Long Term Incentive Plan
27th May 20267:00 amRNSMello Investor Presentation
18th May 20267:00 amRNSAnnual Report, Notice of AGM & Dividend Dates
6th May 20267:00 amRNS-RMajor Contract Win
5th May 20267:00 amRNSHolding(s) in Company
30th Apr 20267:00 amRNSNED Appointment
30th Apr 20267:00 amRNSFinal Results
23rd Apr 20267:00 amRNSNotice of Results & Investor Presentation
21st Apr 20267:01 amRNSRelationship Agreement with Brave Bison
6th Mar 20264:56 pmRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSHolding(s) in Company
3rd Mar 20265:15 pmRNSHolding(s) in Company
3rd Mar 20263:30 pmRNSTVR
2nd Mar 20267:10 amRNSStrategic Investment in System1
2nd Feb 20267:00 amRNSMajor Contract Win
29th Jan 202610:12 amRNSHolding(s) in Company
13th Jan 20267:00 amRNSTrading Update
19th Dec 20253:00 pmRNSUpdate on Issue of Equity
12th Dec 20252:58 pmRNSExercise of Options, Issue of Equity and TVR
5th Dec 20254:00 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSResponse to Press Speculation
29th Oct 20257:00 amRNSAppointment of Joint Broker
24th Oct 20255:09 pmRNSResult of General Meeting
24th Oct 20253:00 pmRNSHolding(s) in Company
22nd Oct 20257:00 amRNSHolding(s) in Company
8th Oct 20252:47 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20251:00 pmRNSHolding(s) in Company
6th Oct 20257:00 amRNSNotice of GM - Recommendation to Vote Against
1st Oct 202512:42 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSRequisition of General Meeting
25th Sep 202510:10 amRNSExercise of LTIP, Director Dealings and TVR
24th Sep 20253:52 pmRNSShareholder Update
23rd Sep 20257:00 amRNSHolding(s) in Company
22nd Sep 202511:32 amRNSHolding(s) in Company
11th Sep 20257:01 amRNSAcquisition and Trading Update
11th Sep 20257:00 amRNSInterim Results
10th Sep 20253:00 pmRNSHolding(s) in Company
5th Sep 20257:00 amRNSNotice of Results & Investor Presentation
1st Sep 20259:15 amRNSHolding(s) in Company
4th Aug 202511:34 amRNSHolding(s) in Company
30th Jul 20257:00 amRNSHolding(s) in Company
22nd Jul 20257:00 amRNSHolding(s) in Company
21st Jul 20257:00 amRNSHolding(s) in Company
18th Jul 202511:30 amRNSSale of MiniMBA and Notice of Results
17th Jul 20255:27 pmRNSHolding(s) in Company
17th Jul 20258:21 amRNSHolding(s) in Company
17th Jul 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.